✦ LIBER ✦

MiR-378 as a biomarker for response to anti-angiogenic treatment in ovarian cancer

✍ Scribed by Chan, John K.; Kiet, Tuyen K.; Blansit, Kevin; Ramasubbaiah, Rashmi; Hilton, Joan F.; Kapp, Daniel S.; Matei, Daniela

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of a predictive bioma

✍ J. Barnett; A. Alvarez-Secord; D. Cohn; C. Leath; B. Peterson; E. Myers; L. Havr 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Germline SNP analysis as a biomarker for

✍ V. Kristensen; S.H. Nordgard; B. Naume; P.E. Lonning; A.L. Borresen-Dale 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Anti-tumor immune response in ovarian ca

✍ Nikos G. Gavalas; Meletios A. Dimopoulos; Aristotelis Bamias 📂 Article 📅 2009 🏛 PAGEPress Publications 🌐 English ⚖ 383 KB

P82 18F-fluorothymidine (FLT)-PET as a b

✍ L. Moretti; C. Willey; C. Quarles; K. Niermann; D. Xiao; T. Tu; B. Lu 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 65 KB

FDG-PET as a pharmacodynamic biomarker f

✍ Mudd, Sarah R.; Voorbach, Martin J.; Reuter, David R.; Tapang, Paul; Hickson, Jo 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 237 KB

Biomarker Profiles and Cytoplasmic Vacuo

✍ A. Mahdavi; S. Chopra; M. Hunter; W. Brewster; I. Ramzy; K.S. Tewari 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 51 KB